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RecoveryA rapidly growing number of studies using inhibition of the contralesional hemisphere after stroke are reporting
improvement inmotor performance of the paretic hand. These studies have used different treatment onset time,
duration and non-invasive methods of inhibition. Whereas these results are encouraging, several questions
regarding the mechanisms of inhibition and the most effective treatment parameters are currently unanswered.
In the present study, we used a rat model of cortical lesion to study the effects of GABA-mediated inactivation on
motor recovery. In particular, we were interested in understanding better the effect of inactivation duration
when it is initiated within hours following a cortical lesion. Cortical lesions were induced with endothelin-1 mi-
croinjections. The contralesional hemisphere was inactivated with continuous infusion of the GABA-A agonist
Muscimol for 3, 7 or 14 days in three different groups of animals. In a fourth group, Muscimol was infused at
slower rate for 14 days to provide additional insights on the relation between the effects of inactivation on the
non-paretic forelimb behavior and the recovery of the paretic forelimb. In spontaneously recovered animals,
the lesion caused a sustained bias to use the non-paretic forelimb and long-lasting grasping deﬁcits with the pa-
retic forelimb. Contralesional inactivation produced a general decrease of behavioral activity, affected the spon-
taneous use of the forelimbs and caused a speciﬁc reduction of the non-paretic forelimb function. The intensity
and the duration of these behavioral effects varied in the different experimental groups. For the paretic forelimb,
increasing inactivation duration accelerated the recovery of grasping function. Both groups with 14 days of inac-
tivation had similar recovery proﬁles and performed better than animals that spontaneously recovered.Whereas
the plateau performance of the paretic forelimb correlatedwith the duration of contralesional inactivation, it was
not correlated with the spontaneous use of the forelimbs or with grasping performance of the non-paretic hand.
Our results support that contralesional inactivation initiated within hours after a cortical lesion can improve re-
covery of the paretic forelimb. In our model, increasing the duration of the inactivation improved motor out-
comes but the spontaneous use and motor performance of the non-paretic forelimb had no impact on
recovery of the paretic forelimb.erms o
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Several studies have shown that following a lesion, there is an in-
crease of cortical excitability in the contralesional hemisphere (Meyer
et al., 1985; Mohajerani et al., 2011; Sakatani et al., 1990). The hyperex-
citability in the contralesional cortex (Buchkremer-Ratzmann et al.,f the Creative Commons
permits non-commercial
riginal author and source
ystème nerveux central
esmarais, Université de
anada.
).
by Elsevier Inc. All rights reser1996) is associated with a diminution of GABAergic inhibition (Witte
and Stoll, 1997) and a reduction of GABA-A receptor binding (Lee
et al., 2011; Qu et al., 1998), suggesting that it may be related to a de-
creased potency of the inhibitory GABAergic system. Longitudinal imag-
ing studies in humans have shown that the contralesional activity is
typically maximal early after the injury and progressively diminishes
with time and recovery (Carey et al., 2006; Jaillard et al., 2005;
Marshall et al., 2000).
In the last few years, several modulatory approaches using non-
invasive stimulation techniques to favor adaptive plasticity and
recovery after stroke have been proposed and are currently being
tested. In particular, many groups are intensively investigating the
effects of inhibition of the contralesional hemisphere on behavioral
recovery (Hummel and Cohen, 2006). The rationale behind the
treatment strategy used in most studies is based on the concept ofved.
19B.K. Mansoori et al. / Experimental Neurology 254 (2014) 18–28interhemispheric imbalance (Liepert et al., 2000; Nowak et al., 2009).
According to this hypothesis, hyperexcitability in the contralesional
hemisphere results in an augmented inhibitory inﬂuence on the
ipsilesional hemisphere. In this manner, the contralesional hemisphere
would interfere with function and adaptive plasticity in the ipsilesional
hemisphere and with recovery of the paretic arm. However, this
hypothesis is far from being universally accepted.
While some studies using protocols of inhibition of the contralesional
cortexwith non-invasive stimulation techniques show improvements in
motor performance of the paretic hand (Khedr et al., 2009; Nowak et al.,
2008; Takeuchi et al., 2005), inhibition of contralesional areaswith atyp-
ically high activity in chronic stroke patients is also shown to interfere
with performance of the paretic hand (Johansen-Berg et al., 2002;
Lotze et al., 2006). To date, only a few studies have used multiple treat-
ments sessions, many of them with different treatment duration and
onset (Boggio et al., 2007; Fregni et al., 2006; Khedr et al., 2009). There-
fore, the effect of inhibition duration on behavioral recovery is virtually
unexplored. No study has yet has tested the effect of contralesional
inhibition initiated within hours following the lesion, when the inter-
hemispheric imbalance should be maximal. Moreover, the mechanisms
through which non-invasive stimulation methods can induce cortical
inhibition and to what extent they act through GABA are not fully
understood, leaving open the question if potentiating GABA-mediated
inhibition of the contralesional hemisphere can improve recovery.
To provide some insight on these issues, we used a well-established
method of inactivation consisting of continuous infusion of the GABA-A
agonistMuscimol (Martin, 1991) in a ratmodel of cortical lesion. In par-
ticular, our objectiveswere to conﬁrm that GABA-mediated inactivation
and very early inactivation could favor recovery, and to study the effect
of duration of contralesional inactivation onmotor outcomes. Of course,
interpretation of our results and their translation to humans should be
done with caution. The inherent differences in the methods used to in-
activate the contralesional hemisphere in our model and humans, and
the much longer durations and intensity of the inactivation we used,
as revealed in the behavior of the non-paretic forelimb, should all be
kept in mind.
These data increase our understanding of the basic interactions
between inactivation of the contralesional hemisphere, behavior of
the non-paretic forelimb and recovery of the paretic forelimb and may
provide useful cues for the development of treatments based on
contralesional inhibition after stroke.
Methods
Animals
A total of 53 Sprague–Dawley rats (Charles River, QC, CA) of approx-
imately 2 months of age and weighing 250–300 g were included in the
study. All animals were housed in solitary standard Plexiglas cages with
reverse day–night cycle (7 am–7 pm). They were handled only during
the dark cycle. Upon their arrival at our facility, animals were familiar-
ized with banana food pellets in the Montoya staircase test
(Biernaskie and Corbett, 2001; Montoya et al., 1991) for 10 work-days
(Fig. 1). To incite reaching behavior in the Montoya test, food access
was carefully monitored during the two weeks of familiarization. For
each rat, the daily foodminimumcorresponded to 5% of its bodyweight.
Rats had free access to 85% of their daily minimum in the home cage.
They could obtain more food to surpass the 100% value in the Montoya
staircase apparatus. On any given day, if the animal did not attain its
daily minimum in the Montoya, additional food was supplied in its
home cage to reach the daily minimum. Baseline data were collected
at the end of the familiarization period. Spontaneous use of forelimbs
in exploratory behavior was documented with the cylinder wall test
(Schallert et al., 2000) and grasping functionwith theMontoya Staircase
test (Montoya et al., 1991). Animals that performed above the inclusion
criteria (see Montoya Staircase test below) were randomly assigned toan experimental group. During the post-lesion period, foodwas restrict-
ed for 12–14h prior to each behavioral testing session and animalswere
given free access to food after testing. The weight of the animals was
recorded daily during the 2 weeks prior to the lesion and weekly after
the lesion. If an animal lost more than 10% of its original body weight
at any point during the experiment, it was excluded. Two animals
from Group 14D were excluded from the study during the recovery
period because of weight loss and seizures. Animals had ad libitum
access to water at all times. Our experimental protocol followed the
guidelines of the Canadian Council on Animal Care and was approved
by the Comité de Déontologie de l'Expérimentation sur les Animaux of
the Université de Montréal.
Cylinder test: measurement of spontaneous forelimb use
To detect spontaneous asymmetrical use of forelimbs, rats were
placed in a transparent cylinder of 19 cm diameter and 33 cm height
for 3–30 min or until 60 touches to the cylinder wall was achieved
(Schallert et al., 2000). Animals were videotaped from above using a
high deﬁnition digital video camera (30 frames/s). The videos were
analyzed frame-by-frame ofﬂine to count the use of paretic versus
non-paretic limbs during vertical exploration of the cylinder wall. The
forelimb asymmetry score was calculated using the following equation:
Asymmetry score
¼ touches with paretic forelimb−touches with nonparetic forelimb
total number of touches
Montoya Staircase test: Grasping and retrieving performance
Ratswere placed in a Plexiglas chamber (6-cmwide, 12-cmhigh and
30-cm long) with a central platform (2.3-cm wide, 6-cm high and 19-
cm long) that supports the weight, separating the right and left fore-
limbs (Biernaskie and Corbett, 2001; Montoya et al., 1991). A pair of
staircases with seven steps on each side was loaded into the Plexiglas
chamber on both sides of the central platform. Each step had a smooth
well that can hold one to three standard 45 mg banana ﬂavored food
pellets (Bioserve Inc., Frenchtown, NJ, USA). During the familiarization
period, animals had a session of Montoya staircase in the morning and
one in the afternoon, the two separated by 3 to 4 h. In a session, the
rats had 4 trials with each hand (8 trials per day in total). Initially, for
each trial, every well on one side of the staircase was ﬁlled with 3
food pellets and 15minwere given to retrieve the pellets. In the follow-
ing days, the number of pellets in each well and the time provided was
progressively tapered according to the performance of the rat. However,
by the 8th day, only one pellet per well and 3min per trial were given to
all rats. On the 9th and 10th days of the familiarization period, the per-
formance in terms of the number of eaten pellets was recorded and
used to establish if the animal reached our inclusion criteria. To be in-
cluded in the study, rats needed to eat 4 out of 7 pellets in 3 of the 4 trials
on both dayswith oneof the two arms. Based on these criteria, 9 animals
were excluded from the study. The lesionwas induced in the cortex con-
tralateral to the arm with the best performance score.
Surgical procedures
All surgical procedures were conducted aseptically. Anesthesia was
induced with Ketamine (80 mg/kg, intra-peritoneal) and maintained
with isoﬂurane (~2% in 100% oxygen) delivered via a custom-made
facial mask adapted to our stereotaxic frame. Pulse rate and oxygen
saturation were monitored and documented during the surgery. A
self-regulating heating blanket (Harvard Apparatus, Holliston, MA)
was used to maintain body temperature during the surgery. A midline
incision was made to expose the skull and neck muscles. A small
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the cisterna magna and reduce intracranial pressure.
In order to conﬁrm the location of the motor areas of 3-month-old
Sprague Dawley rats, we conducted intracortical microstimulation
(ICMS) mapping experiments in naïve animals (n = 3) (Fig. 1B).
Following craniotomy and durectomy, anesthesia was switched to
ketamine hydrochloride (~10 mg/kg/10 min; intraperitoneal) for the
collection of electrophysiological data. A glass coated tungsten
microelectrode (~1 MΩ) was used for electrical stimulation applied at
a depth of ~1600 μm. Stimulation consisted of a 40 ms train of 13
monophasic cathodal pulses of 200 μs delivered at 350 Hz from an
electrically isolated, constant current stimulator (Dancause et al.,
2006; Nudo et al., 1992, 1996). Pulse trains were repeated at 1 Hz
intervals; current was ≤100 μA. Microelectrode interpenetration
distances were ~333 μm. Stimulations were done to identify the caudal
and rostral forelimb areas (CFA and RFA). The two areas were typically
separated with neck and vibrissa representations. Based on ICMS
maps, we selected the stereotaxic coordinates for six injections ofFig. 1.Experimental design. A) Time course of events in reference to the lesion. Baseline datawe
a baseline performance score. Following the cortical lesion, data were collected twice in the
intervention period show the duration of inactivation in different experimental groups. B) Lo
ICMS map in a naïve animal of comparable age and weight to animals used in the present st
(RFA; orange). Each dot is a penetration site where microstimulations were delivered. Bottom p
ered for 56 days (Group Lesionno pump). The lesion was in the CFA and spared the RFA. Evoked
stereotaxic coordinates in relation to the cortical motor map collected in the naïve animal show
ET-1 injections targeted the CFA. D) Cartoon showing the location of the cannula and osmoticendothelin-1 (ET-1) as in Fang and collaborators (Fang et al., 2010)
(Fig. 1C). ICMS mapping was conducted in additional animals (n = 3)
at the endof the recovery period (day60 after the lesion) and conﬁrmed
that the lesion destroyed a large portion of the CFA and appeared to
leave the RFA intact (Fig. 1B).
To induce the cortical lesion, six 0.6-mm holes were drilled over the
caudal forelimb area (CFA) based on stereotaxic coordinates (+1.5,
+0.5, −0.5 mm anteroposterior, +2.5, +3.5 mm mediolateral to
bregma; Fig. 1B) (Fang et al., 2010). Using a 1 μl Hamilton syringe, a
microinjection of endothelin-1 (ET1) (EMD chemicals, CA, USA) was
made in each hole at a depth of 1.5 mm in the cortex (0.33 μl, 0.3 μg/μl,
3 nl/s). Following each injection of endothelin-1 (ET-1), the holes were
sealed with bone wax. After the lesion induction, an additional 0.6-mm
holewas drilled over the center of the contralesional CFA (+0.5mm an-
terior and +3 mm lateral to bregma). A cannula (0.36 mm, brain infu-
sion kit 1; Alzet, CA, USA) was implanted at the depth of 1.5 mm
below the cortical surface and secured in place with acrylic cement
(Fig. 1D). The cannula was connected to an osmotic pump ﬁlled withre collected on the 9th and 10th days of the familiarization period and averaged to establish
ﬁrst week, on days 4 and 7, and then once per week until day 56. Horizontal bars in the
cation of ET-1 lesion in relation to motor representations. The top panel shows a typical
udy. Contours outline the caudal forelimb area (CFA; red) and the rostral forelimb area
anel shows an example of the impact of the ET-1 lesion in a rat that spontaneously recov-
movements are color-coded. C) Cartoon showing the location of ET-1 injections based on
n in B. The red dots show the location of ET-1 injections and the blue dot the cannula. The
pump.
Table 1
Animal groups and characteristics.
Group Inactivation protocol ET1 Lesion CL hemisphere Osmotic Pump type Muscimol concentration Infusion rate (μl/h) n
Lesionno pump No inactivation Yes Metal rod – – – 9
3D 3 day Yes Cannula Alzet 1007D 10mM 0.5 8
7D 7 day Yes Cannula Alzet 1007D 10mM 0.5 8
14D 14 day Yes Cannula Alzet 2002 10 mM 0.5 8
14Dslow 14 day, slow rate Yes Cannula Alzet 1002 10 mM 0.25 9
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agonist. Muscimol was chosen because it is a well-established and sim-
ple way to reliably inactivate neural tissue for sustained periods without
causing damage (Martin, 1991; Martin et al., 1999; Reiter and Stryker,
1988). Neck muscles were then glued back with dermal adhesive and
the skin sutured. After the surgery, animals received a regimen of pain,
anti-inﬂammatory and antibiotic medication and their recovery was
closely followed.Experimental groups
In 3 different experimental groups (Table 1), the contralesional
hemisphere was inactivated for 3, 7 or 14 days with infusion of
Muscimol (10 mM) at a rate of 0.5 μl/h (Groups 3D, 7D and 14D)
beginning within 2 h following the lesion. An additional group (Group
14Dslow) also received 14 days of Muscimol infusion, but delivered at a
slower rate (0.25 μl/h). Because no pumpmodel could provide infusion
of 3 days, the plastic tube between the pump and the cannula was cut
and sealed in a minor procedure 72 h after the lesion in Group 3D.
With our method of inactivation, the main concern was that the
lesion made by the cannula affected the behavior of the non-paretic
forelimb. Therefore, in control animals (Group Lesionno pump), to
reproduce the mechanical damage caused by the cannula, a stainless
steel rod of the same diameter as the cannula was lowered at a depth
of 1.5 mm and immobilized in acrylic. To rule out the possibility that
vehicle infusion in the contralesional hemisphere affected behavior,
a pump infusing saline (0.5 μl/h) for 14 days was implanted after
the cortical lesion in additional control rats (n= 3). No statistical differ-
ence of performance on theMontoya staircase tests was found betweenFig. 2. Spread of muscimol infusion in different experimental groups. We infused ﬂuorophore
groups. Coronal sections of animals in which Muscimol was infused for A) 3 days at 0.5 μl/h
14 days at 0.25 μl/h (Group 14Dslow) are shown. We found that the radius of diffusion was lessthe two control groups (One way ANOVA paretic hand F = 0.10; p =
0.76; non-paretic hand F = 0.23 p = 0.64). Thus, as in intact animals
(Martin et al., 2000), vehicle infusion in the contralesional motor cortex
with these methods does not affect behavior. On post-lesion day
56, the animal was killed, the brain ﬁxed, cryoprotected and cut
coronally for anatomical reconstruction and estimation of the lesion
size (MicroBrightField, VT, USA).Reversible inactivation using Muscimol infusion of long duration
The effects of chronic brain inactivation using GABA-A agonist
Muscimol on neural activity and behavior have been carefully docu-
mented (Hata and Stryker, 1994; Martin, 1991; Martin and Ghez,
1999; Reiter and Stryker, 1988). In kittens, recording of neural activity
in the visual cortex following infusion with osmotic pumps for 8 to 11
days with parameters similar to the ones we used (0.5 μl/h of 10 Mm)
showed that inactivation extended over a radius of 1 to 3.5 mm
(Reiter and Stryker, 1988). To conﬁrm that our injection protocol
resulted in comparable spread, we ﬁlled the osmotic pump with
Fluorophore-conjugated Muscimol molecule (BODIPY® TMR-X conju-
gate; Molecular probes). We infused ﬂuorescent Muscimol at 0.5 μl/h
for 3 days in one animal (Group 3D; Fig. 2A), for 7 days (Group 7D;
Fig. 2B) in one animal and for 13 days (Group 14D; Fig. 2C) in one
animal. Whereas the pump model infuses for 14 days, we chose to
perfuse on day 13 to insure the infusionwas still at itsmaximum. Finally
we infused ﬂuorescent Muscimol at 0.25 μl/h in one animal for 13 days
(Group 14Dslow; Fig. 2D). Following the infusion period, animals were
perfused, and the tissue processed according to an established protocol
using this product (Allen et al., 2008). Coronal sections were inspected-conjugated Muscimol to evaluate the spread of muscimol in our different experimental
(Group 3D), B) 7 days at 0.5 μl/h (Group 7D), C) 14 days at 0.5 μl/h (Group 14D) and D)
than 2 mm in all animals. Scale bar = 5 mm.
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with a 10× objective. On each section where the ﬂuorescent Muscimol
was visible, digital photographs of the entire contralesional hemisphere
were taken. Aperture and exposure were kept constant between
sections and animals. Digital pictures were imported and aligned in
Adobe Photoshop (Adobe Systems, San Jose, CA). To identify the spread
of the ﬂuorescence on each section, brightness was decreased. This
typically facilitated the identiﬁcation of a dense core and a narrow
halo. In both these regions, the ﬂuorescence was opaque and the details
of the tissue difﬁcult to see. Around the core and halo, often, another
transition zone was visible. In this region, the tissue was only slightly
brighter than the general background. The details of the tissue were
discernable in this area. We included only the core and the narrow
halo in our calculation of the spread of Muscimol. The limits were
identiﬁed by one evaluator and conﬁrmed by a second thatwas blinded
to the infusion protocol used for the animal.
We ﬁrst found the coronal section with the maximal medio-lateral
radius of the Muscimol spread and measured its radius (ML radius).
Then, the anteroposterior (AP) radius was calculated from the span of
sections showing the ﬂuorescence
AP radius ¼ n 40 μm thick section 2
where n = the number of sections with ﬂuorescent Muscimol.
For each animal, the diffusion radius was the average of the ML and
AP radii.
We found that Groups 3D and 7D had identical diffusion radius
(1.2 mm). Group 14Dslow had the smallest (1.1 mm) and Group 14D
the largest radius (1.9 mm) of Muscimol diffusion. However, these
differences are small and their signiﬁcance questionable considering
the variability of the diffusion radius reported by others (Reiter and
Stryker, 1988). Thus, analyses and conclusions in the present set ofFig. 3. Responses to intracortical microstimulation (ICMS) following sustained muscimol infusi
sphere using ICMS in A) one animal fromGroups Lesionno pump, B) one animal fromGroup 7D an
surface of the cortex (asterisk). Evoked movements are color-coded and the twomotor represe
the tissue in the CFAwas responsive to stimulation, with no apparent difference between the an
damage of the tissue. D) ICMS map of the animal from Group 14D on which the range of Musc
Group 14Dslow) and largest radius (1.9 mm, Group 14D) of ﬂuorescent Muscimol spread.experiments are based on the behavioral effect of the inactivation on
the non-paretic forelimb and not on the rate of infusion or hypothetical
radius of inactivation.
To show that in ourmodel,Muscimol effectively induced a reversible
contralesional inactivation and did not cause permanent damage to the
contralesional hemisphere, we conducted a series of controls. First, we
conducted ICMS mapping in the contralesional hemisphere at the end
of the recovery period in one animal of Group Lesionno pump, Group 7D
and Group 14D (Fig. 3). We found that we could evoke movements
from the cortex immediately surrounding the cannula using normal
current intensity and could not differentiate the responses in the ani-
mals that received Muscimol from the Lesionno pump or from naïve ani-
mals. We also visually inspected the Nissl stained tissue around the
cannula in all of our animals and found no differences between
experimental groups (Fig. 4). To further conﬁrm this ﬁnding, we
calculated the size of the lesion made by the cannula in the con-
tralesional hemisphere in Nissl-stained sections for Groups 14D and
14Dslow, the two groups with Muscimol infusion of the longest dura-
tion, and compared it to the lesions made by the metal rod in Group
Lesionno pump. In the contralesional hemisphere, the cannula made a
small mechanical lesion in all groups. On average for Groups Lesionno
pump, 14D and 14Dslow, the lesion made by the cannula was 0.15 mm3,
corresponding to 1.6% of the volume of the ET-1 lesion. A one-way
ANOVA between the three groups found no signiﬁcant difference (F
= 2.15, p = 0.16) and, combining Groups 14D+ 14Dslow and compar-
ing the lesion size to the Group Lesionno pump also did not show any dif-
ference (t-test; equal variance not assumed: F = 0.88, p = 0.40).
Altogether, these data support that Muscimol transiently
inactivated the contralesional hemisphere and did not result in any
permanent damage in our experimental groups. Thus, whereas
there is permanent damage to the contralesional hemisphere, it
was a small mechanical damage caused by the insertion of theon. At the end of the recovery period, we derived motor maps in the contralesional hemi-
d C) one animal fromGroup 14D. In all cases, only a small cortical lesionwas visible on the
ntations, the caudal (CFA) and the rostral forelimb area (RFA), are outlined.We found that
imals. These data support that sustained infusion ofMuscimol did not result in permanent
imol diffusion we found is superimposed (see Fig. 2). Circles show the smallest (1.1 mm,
Fig. 4. Histological evaluation of the tissue surrounding the cannula in the contralesional
hemisphere. A) Example of a Nissl stained coronal section of rat of Group Lesionno pump at
+0.5 mm AP. Asterisk shows the position of the cannula. The black box outlines the tissue
shown at higher magniﬁcation on the left. Scale bar = 1 mm. Inset width = 0.5 mm.
B) Example of a Nissl stained coronal section of rat of Group 14D at +0.5 mm AP. Small ar-
rows show examples of ICMS electrode penetration tracks. There was no obvious difference
in the tissue between animals infusedwithMuscimol and animals that had ametal rod in the
Group Lesionno pump. In all animals, the lesion made by the cannula was only visible in one
Nissl-stained section, supporting that the lesion did not extend into the AP axis.
23B.K. Mansoori et al. / Experimental Neurology 254 (2014) 18–28cannula that was of identical size across experimental groups and
controlled for in our Group Lesionno pump.Histology and anatomical reconstruction
At the end of the experiments, animals were given a lethal dose of
sodium pentobarbital and were transcardially perfused with
heparinized 0.1 M phosphate buffered saline (PBS) followed by 4%
paraformaldehyde in 0.1 M PBS. Brains were extracted and post-ﬁxed
in 4% paraformaldehyde. The brains were cryoprotected in a solution
of 20% sucrose and 2% dimethyl sulfoxide (DMSO) over-night followed
by 20% sucrose for 48 h and quickly frozen at−55 °C utilizing methylFig. 5. Histological evaluation of the endothelin-1 lesion size. A) Example of a Nissl stained cor
block of brain of identical sizewas reconstructed inNeurolucida (Microbrightﬁeld, inc.) for each
of the contralesional hemisphere of the block (see Methods section). There was no difference obutane and stored at−80 °C (Brocard et al., 2010). Coronal sections
were cut with a cryostat (40 μm thickness). One out of six sections
was Nissl stained and used for analysis of the lesion size and location.
The lesion size was calculated with a software (MicroBrightField,
Colchester, VT, USA) using the following formula:
Lesion size %ð Þ ¼ volume of contralesional cortex−volume of ipsilesional cortex
volume of contralesional hemisphere
 100
Statistical analysis of experimental results
All values are reported as mean ± SEM, unless speciﬁed, and
signiﬁcance was considered at p b 0.05. Lesion volume between groups
of animals was compared with a one-way ANOVA. For the Cylinder and
Montoya tests, two repeated measures ANOVAs were conducted using
animal group, time and group x time as factors and Tukey-HSD for
post-hoc testing. Pre-lesion baseline data and post-intervention
recovery period data (day 21 to 56 post-lesion) were included in this
analysis. Statistical analysis during the intervention period was
impossible because behavioral data could not be collected in all animals
(see Results section).
Mixed modeling, adjusting for correlations between individual
measurements over time, was conducted to identify the plateau
performance of the paretic limb on the Montoya test. Regressions
were used to investigate how different factors correlated with this
plateau performance for each rat. The autoregressive correlation
structure, which indicates that for each individual, observations taken
close in time tend to be more highly correlated than observations
taken far apart in time, was assumed in the analysis. To avoid making
unfounded assumptions on the shape of the effect of time, we treated
time as a categorical variable in the analysis. Regression results report
the Spearman's correlation coefﬁcient and t-test on the slope of the
distribution. Statistical signiﬁcance for the t-testwas adjusted according
to the Bonferroni correction factor (p b 0.017).
Results
Cortical lesions
The average ET-1 induced lesion volumewas 6.8±2.5mm3 (Mean±
standard deviation). As reported by others using a similar ET-1 lesion
protocol (Fang et al., 2010), lesions destroyed all cortical layers and
there was no signiﬁcant difference of lesion size between experimental
groups (F= 0.206, P= 0.892) (Fig. 5).onal section of rat brain at AP +0.5 mm from bregma of the ipsilesional hemisphere. B) A
animal. To compare experimental groups, the lesion volumewasnormalized to the volume
f lesion volume between experimental groups.
Fig. 7. Non-paretic forelimb grasping performance on the Montoya test. The intervention
period is highlighted with gray background. In this period, data points with n ≥ 5 are
shown even if they were not included in the statistical analyses. Inactivation in Group
14D resulted in sustained deﬁcits of the non-paretic forelimb until day 35 after the lesion.
Slower infusion rate (Group 14Dslow) induced similar deﬁcits. Symbols show signiﬁcant
differences from Group Lesionno pump.
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During the infusion of Muscimol, rats were typically much less
active. Some rats made no movement in the Montoya staircase tests
(Fig. 6). In Group 3D, some rats were still inactive at day 7 after the
lesion, showing that the reversal of the effects of inactivation took
more than four days in some cases. Groups 7D and 14D were more
severely affected. More than half of the animals in these groups were
inactive in the Montoya staircase in the ﬁrst week during infusion of
Muscimol. The side effects of Muscimol became problematic with time
for some animals of Group 14D, and two rats from this group had to
be excluded (see Methods section). Using a slower rate of infusion
(Group 14Dslow) diminished the inactivity caused by infusion of
Muscimol. In fact, the general behavior of animals from Group 14Dslow
was the least affected by Muscimol delivery, supporting that the rate
of infusion had a greater inﬂuence on these deleterious effects than
the duration of inactivation.
The effect of inactivation on grasping performance of the non-paretic
forelimb
The animals receiving Muscimol showed signs of impairments of
grasping performance with the non-paretic forelimb in the Montoya
test, conﬁrming the effectiveness of the pharmacological agent. The
analysis of the performance of the non-paretic forelimb in the Montoya
testwas done on the baseline and the post-intervention recovery period
to include all animals in each group. TheANOVA showed a signiﬁcant ef-
fect of group (F = 9.237, P b 0.001), time (F = 49.244, P b 0.001), and
time × group (F = 11.034, P b 0.001). The pre-lesion performance
was similar between all groups. In Group Lesionno pump, the ET-1 lesion
and the mechanical damage caused by the metal rod did not decrease
the performance of the non-paretic forelimb to a signiﬁcant level
(Fig. 7). In Groups 3D and 7D, whereas inactivation affected grasping
during the intervention period, performance was not statistically
different from pre-lesion baseline or from Group Lesionno pump in the
post-intervention recovery period. The effect of inactivation on the
non-paretic forelimb function of animals in Group 14D was strikingly
different. Grasping performance was signiﬁcantly lower than pre-
lesion baseline and from Group Lesionno pump until the 35th day after
the lesion. Thus 14 days of inactivation resulted in behavioral
impairments of the non-paretic forelimb that lasted more than 2 weeksFig. 6. Side effects of contralesional inactivation. During Muscimol delivery the different
experimental groups showed variable degrees of inactivity in the Montoya staircase test.
Rats were given 15 min in the Montoya to perform the task for each trial. The graphs
show the percentage of animals in each experimental group that were inactive in the
test for that entire period and from which no behavioral data could be collected.after the end of infusion. Using a slower infusion rate for 14 days in
Group 14Dslow did not affect the level of impairments on grasping perfor-
mance caused by the inactivation. Togetherwith results from Fig. 6, these
data show that a slower rate of infusion had less detrimental effects on
the general state of the animals but still had a comparable impact on
the function of the non-paretic forelimb.The effect of inactivation on spontaneous use of forelimbs
Rats also reared less often during the infusion of Muscimol. This was
particularly true for animals in Groups 7D and 14D and less in Groups
3D and 14Dslow (missing data points in Fig. 8). We found that animals
either did not touch the cylinderwall at all orwhen they did explore, weFig. 8. The effect of inactivation on spontaneous use of forelimbs. Laterality scores in the
cylinder test. Positive values highlight an increased use of the paretic forelimb in relation
to the pre-lesion behavior of the animal. During the infusion period, data pointswith n≥ 5
are shown even if theywere not included in the statistical analyses. InGroup Lesionno pump,
the lesion caused a bias for thenon-paretic forelimb. In contrast, inactivation inGroups 7D,
14D and 14Dslow resulted in a bias to use the paretic forelimb. The laterality index in
Group 14D was signiﬁcantly different from Group Lesionno pump throughout recovery.
Symbols show signiﬁcant differences from Group Lesionno pump.
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collection session with less than 55 touches, but more than 22. We
considered that more than 20 touches were sufﬁcient to provide an
average for that session and thus included that session in the group
average. Four of these 5 sessions were during the infusion of Muscimol
and thus, were not included in the statistical analyses. In all other data
collection sessions (n = 457), we obtained more than 55 touches.
Thus, the laterality scores obtained for each rat, in any session, are
robust.
Analysis of the spontaneous use of the forelimbs in the cylinder
test was done for the post-intervention recovery period and includes
all animals in each group. The ANOVA showed a signiﬁcant effect
of group (F = 32.549, P b 0.001) and group × time (F =
4.338, p b 0.001). After the cortical lesion, animals in Group Lesionno
pump used their non-paretic forelimb more often throughout the post-
intervention recovery period (Fig. 8). Thus, the lesion created a
persistent bias for the use of the non-paretic forelimb. Following inacti-
vation of short duration (Group 3D), there was an initial bias toward
the use of the non-paretic forelimb. However, the animals recovered
symmetrical use of their forelimbs at day 28. Inactivation of longer du-
ration caused an initial bias to use the paretic forelimb. Whereas ani-
mals in Group 7D returned to symmetrical use of their forelimb by
day 28, the bias for the paretic forearm persisted until day 35 in
Group 14D. The laterality index of Group 14D was different from con-
trols throughout recovery. The use of a slower infusion rate for 14
days in Group 14Dslow still resulted in a bias to use the paretic forelimb
on day 21. However, the animals returned to a symmetrical forelimb
use during spontaneous exploration on day 28 and their laterality
index was not different fromGroup Lesionno pump, much like for Groups
3D and 7D.
The effect of inactivation on post-intervention recovery of the paretic
forelimb
In the Montoya staircase test, grasping performance of the paretic
forelimb showed a signiﬁcant effect of group (F = 6.016, P b 0.001),
time (F = 49.528, P b 0.001) and time × group (F = 5.739, P b 0.001).
Pre-lesion performance was similar among all experimental groupsFig. 9. Effects of inactivation on the recovery of the paretic forelimb. Grasping performance of
the paretic forelimb in theMontoya test. Group Lesionno pump recovered to baseline level only
by day 56. The performance was worsened by the inactivation during the intervention
period. However, in the post-intervention recovery period, animals with inactivation recov-
ered better than controls. Symbols show signiﬁcant differences from Group Lesionno pump.(Fig. 9). The Group Lesionno pump had signiﬁcant deﬁcits until the 56th
day after the lesion. Inactivation of the contralesional hemisphere initial-
lyworsened the paretic forelimb function during the intervention period
but then improved it in the post-intervention recovery period. Groups
3D and 7D recovered faster from the lesion than Group Lesionno pump.
They reached pre-lesion performance at days 35 and 28, respectively,
and Group 7D transiently performed better than Group Lesionno pump
on day 28. Group 14D had signiﬁcant deﬁcits and poorer performance
than other groups on day 21. However, by day 28 and for the rest of
the post-intervention recovery period, these animals had no deﬁcits
and performed signiﬁcantly better than Group Lesionno pump. Grasping
performance of Group 14Dslow was similar to other groups and better
than Group 14D on day 21. This group performed better than Group
Lesionno pump from days 28 to 49. Thus, the beneﬁcial effects of inactiva-
tion on recovery of the paretic forelimb were mostly preserved when a
slower infusion rate was used to inactivate the contralesional hemi-
sphere for 14 days. These results support that the beneﬁcial effect of
contralesional inactivation dependsmainly on the duration of the inacti-
vation and not the rate of infusion.
The effect of non-paretic forelimb behavior and inactivation duration on
ﬁnal level of recovery
We found that plateau performance on the Montoya test for the
paretic limb was reached at day 7 for Group Lesionno pump, day 21 for
Group 3D, day 28 for Group 7D and day 35 for Groups 14D and
14Dslow. Thus, from day 35 to day 56, all groups had a stable level of
performance. For each animal, we calculated the average Montoya
score between days 35 and 56 to obtain a ‘plateau performance score’.
Three regressions were conducted to study factors potentially
correlating with the plateau performance score.
First, we performed a regression between the asymmetry score on
the Cylinder test at day 21 and the plateau performance score for each
animal (Fig. 10A). A positive correlation between these factors would
suggest that increased spontaneous use of the paretic forelimb at the
beginning of the post-intervention recovery period results in better
recovery of the paretic forelimb. We found a weak correlation between
the two factors (R = 0.28) and a non-signiﬁcant slope of the
distribution (p = 0.13).
Second, we performed a regression analysis between the Montoya
score of non-paretic forelimb at day 21 and the plateau performance
score of the paretic forelimb (Fig. 10B). Here, a negative correlation
between these factors suggests that poor performance of the non-
paretic forelimb at the beginning of the post-intervention period results
in better recovery of the paretic forelimb. We found a weak negative
correlation between the two factors (R = −0.12) and a non-
signiﬁcant slope of the distribution (p = 0.58).
A third regressionwas conducted between the inactivation duration
value (0, 3, 7, 14) and the plateau performance score to test how well
the inactivation duration correlated with the level of recovery
(Fig. 10C). A positive correlation between these factors suggests that a
longer duration of inactivation results in better recovery of the paretic
forelimb. The correlation between the two factors was higher than
other variables tested (R = 0.52) and the slope of the distribution was
highly signiﬁcant (p = 0.0004). Overall, the correlation analyses
suggest that the level of recovery was weakly inﬂuenced by the
spontaneous use of forelimbs or on grasping function of the non-
paretic forelimb after inactivation of the contralesional hemisphere. In
contrast, the duration of inactivation had a great impact.
Discussion
We used a rat model of cortical lesion to study the basic interaction
between GABA-mediated inactivation of the contralesional hemisphere
and behavioral recovery. Inactivationwas initiated rapidly following the
lesion and was maintained for increasing durations in different groups
Fig. 10. Correlation analyses of factors potentially involved in the recovery of the
paretic forelimb. A) Correlation between the spontaneous use of forelimbs at the
beginning of the post-intervention period and level of recovery of the paretic
forelimb. The plot shows the asymmetry scores at day 21 and the average Montoya
score of the paretic forelimb between days 35 and 56 after the lesion (plateau
performance score). When more than one animal had the same laterality score,
their plateau performance scores were averaged. B) Correlation between non-
paretic forelimb function at the beginning of the post-intervention period and
level of recovery of the paretic forelimb. The plot shows the Montoya score of non-
paretic forelimb at day 21 and the plateau performance score of the paretic forelimb.
When animals had the same Montoya score with the non-paretic forelimb, their
plateau performance scores were averaged. C) Correlation between duration of
inactivation and level of recovery of the paretic forelimb. The plot shows the
duration of inactivation and the plateau performance score of the paretic forelimb.
The plateau performance scores of the animals for each of the four time points (0,
3, 7, 14) are shown.
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in general inactivity of the animals, impaired the use of the non-
paretic forelimb and worsened the function of the paretic forelimb.
These effects were much greater than what is induced with non-
invasive stimulation methods in humans, something that should be
kept in mind when interpreting the results. In the post-intervention
recovery period, the adverse effects of inactivation progressively
reverted. Rats with inactivation of the contralesional hemisphere
recovered their grasping skills faster than untreated animals and the
time of recovery was shorter for animals with inactivation of longer
duration. In comparison to controls, the grasping function of the paretic
forelimb showed a tendency to be greater following inactivation of
longer durations. In rats with 14 days of inactivation, this trend reached
signiﬁcance four weeks after the lesion and remained signiﬁcant for the
rest of the experiment. Using a slower infusion rate to inhibit the
contralesional hemisphere for 14 days diminished the deleterious effect
on the general behavior during inactivation while still preserving most
of the beneﬁcial effects on chronic recovery. Final recovery scores
were correlated to the duration of inactivation but not to the
spontaneous use of the forelimbs or the function of the non-paretic
forelimb.
In our model, we found that acute inactivation of the contralesional
hemisphere can favor recovery of the paretic forelimb. Inactivation of
longer duration results in more pronounced and sustained recovery of
function. Final recovery is more affected by the duration of inactivation
than on the effects of inactivation on general behavior or on the non-
paretic forelimb.
Spontaneous recovery following ET-1 lesions in the sensorimotor cortex of
rats
Cortical microinjections of ET-1 are now a common approach to
produce focal cortical lesions in rats (Windle et al., 2006). As shown
by others using similar lesion protocols, we found relatively small
variability in lesion size among animals, facilitating comparison of
behavioral recovery between experimental groups (Fang et al., 2010).
In spontaneously recovering animals, the Group Lesionno pump in the
present study, lesions caused typical motor deﬁcits of the paretic
forelimb. The Cylinder and Montoya tests both revealed initial deﬁcits
of the paretic forelimb that recovered in the ﬁrst 3 weeks. The recovery
then slowed to reach a plateau and animals had small but persistent
long-term deﬁcits (Biernaskie and Corbett, 2001).
For the non-paretic forelimb, we found no change of performance in
the Montoya test after lesion. Together with Cylinder test results, our
data conﬁrm that the mechanical damage caused by implantation of
the cannula did not affect the function of the non-paretic forelimb.
Effects of GABA-mediated inactivation on general behavioral inactivity
We inactivated the contralesional hemisphere with chronic infusion
of the GABA-A agonistMuscimol. Thismethod has carefully documented
effects on neural activity and behavior. With the parameters of infusion
we used to test the effect of duration on recovery (10 mM, 0.5 μl/h) for
8 to 11 days, Muscimol was shown to inhibit activity within a radius of
1 to 3.5 mm from the cannula (Reiter and Stryker, 1988). Using ﬂuores-
cent Muscimol, we found that the radius of diffusion in our experiments
had similar values, ranging from 1.1 mm (Group 14Dslow) to 1.9 mm
(Group 14D). In animals of Groups 3D, 7D and 14D, the Muscimol
appeared to diffuse further below the cortex, affecting the callosum
and the dorsal striatum (Fig. 2). In Group 14Dslow, Muscimol appeared
to be limited to the cortex. It is thus possible that the general inactivity,
which we found to be the lowest in Group 14Dslow, is a result of a spread
of Muscimol to these additional structures. However, such conclusions
must be taken with caution and warrant more data, speciﬁcally
knowing the variability of Muscimol diffusion reported by others using
similar techniques (Reiter and Stryker, 1988).
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Muscimol infusion after cortical lesion could have inﬂuenced the level
of recovery of the paretic limb. However, using a slower infusion rate
for 14 days (Group 14Dslow) was less detrimental to the general behav-
ioral activity than 3 days of inactivation using the faster infusion rate
(Group 3D). As the recovery of the paretic limb was comparable in
Groups 14D and 14Dslow (Fig. 9), respectively the group with the most
and least pronounced effects on general behavioral inactivity (Fig. 6),
it appears that this inactivity has little effect on the recovery of the
paretic forelimb.Effects of GABA-mediated inactivation on the function of the non-paretic
forelimb
In kittens, after sustained inhibition that lasts for 30 days, there is no
injury to the inhibited tissue and grasping function returns to normal
within 2–3 days (Martin et al., 2000). In adult rats following cortical
lesions, we found that similar parameters ofMuscimol infusion resulted
in more sustained behavioral deﬁcits of the non-paretic forelimb.
Following 14 days of inactivation, animals had signiﬁcantly poorer
grasping performance with the non-paretic forelimb 3 weeks after the
end of Muscimol delivery. It is possible that the volume of inactivation
in relation to the small brain size of the rat caused these effects. An
alternative explanation may be that the cortical lesion potentiated the
effects of inactivation in the contralesional hemisphere. It is well
known that lesions triggermultiple changes in the contralesional cortex
(Buchkremer-Ratzmann et al., 1996; Jones and Schallert, 1994), some of
which can increase skill learning of the non-paretic arm (Bury and
Jones, 2002). Acute inhibition of this hemisphere after a lesion could
have a particularly stable impact on the non-paretic forelimb. In
humans, it may prevent patients from developing useful compensatory
strategies with the non-paretic forelimb, something that should be
investigated further.
The sustained functional impact on the non-paretic forelimb caused
by the 14 days inactivation raises a fundamental question. Are function-
al gains of the paretic forelimb due to central effects of the inhibition,
increased use and practice with the paretic forelimb or a reversal of
learned non-use (Taub, 2000)? This issue cannot be completely
addressed with the present data. However, our regression analyses
show that the spontaneous use and grasping function of the non-
paretic forelimb were poorly correlated to the recovery of the paretic
forelimb. In contrast, duration of inactivation was highly correlated
with the ﬁnal level of recovery, suggesting that inhibition duration is
much more critical and thus that central mechanisms were more
involved in the recovery of the paretic forelimb. Following lesions in
the CFA, increased use and motor learning with the non-paretic
forelimb can decrease the recovery of the paretic arm (Allred and
Jones, 2008; Allred et al., 2005). The adverse effects of the non-paretic
forelimb behavior on recovery are not seen in animals that sustain a
bilateral CFA injury or a partial callosal transection (Allred et al.,
2010). These data suggest that the negative effect of the non-paretic
forelimb training is mediated through the contralesional cortex and its
callosal interactions with the ipsilesional hemisphere. Similarly, it is
possible that the inactivation in our model improved non-paretic
forelimb recovery by limiting the interhemispheric inﬂuence of the
contralesional CFA on the ipsilesional hemisphere.
Finally, it is worth mentioning that the effects on general motor
behaviors or on the non-paretic forelimb we found have not been
reported in human studies using inhibition of the contralesional
hemisphere after stroke. These results support that in our model, not
only was the duration of inactivation longer, but inactivation was also
more profound than what has been used so far in human protocols.
These differences should be taken into consideration in the interpreta-
tion of the results. However, the improved recovery of the paretic
forelimb, and the absence of long-term adverse effects in any of ourexperimental groups, suggest that inhibition of longer duration and
higher intensity could be beneﬁcial.The effects of inactivation duration on the recovery of grasping function of
the paretic forelimb
In humans, hyperexcitability of the contralesional hemisphere
has been shown in several studies and is generally attributed to
GABA down regulation (Buteﬁsch et al., 2003). In rodents, there is a
rapid increase of somatosensory evoked potentials in the
contralesional cortex (Sakatani et al., 1990). After a few days, the
contralesional hyperexcitability (Buchkremer-Ratzmann et al.,
1996) is associated with a reduction of GABA-A receptors (Qu et al.,
1998). According to the interhemispheric imbalance hypothesis,
the contralesional hyperexcitabilty is thought to contribute to
ipsilesional diaschisis and to interfere with recovery of the paretic
forelimb through an increase of interhemispheric inhibition (Liepert
et al., 2000; Nowak et al., 2009).
In the present study, inactivation of neural activity in the
contralesional hemisphere with a GABA-agonist initially resulted in a
decrease of function of the paretic forelimb. Similar short-term
detrimental effects to the paretic forelimb have been reported in mice
after traumatic cortical injury (Lee et al., 2011). In our study, following
recovery for a longer period, we found that these detrimental effects
are transient. All experimental groups showed that GABA-mediated
inactivation of the contralesional hemisphere initiated rapidly after
the lesion can improve the rate and/or extent of recovery of the paretic
forelimb.
In the present experiments, we chose to initiate contralesional
inactivation within hours following the lesion. Longitudinal imaging
studies in humans show that the increased contralesional activity is at
its highest early after the lesion and is progressively resorbed with
time and recovery (Jaillard et al., 2005; Marshall et al., 2000).
Accordingly, inhibition of the contralesional hemisphere early after
lesion should be most beneﬁcial to recovery. Only a few human studies
have initiated treatmentwithin theﬁrstweek following stroke and their
results indicate an improvement of recovery of the paretic forelimb
(Khedr et al., 2009, 2010). However, early interventions, such as
forced-use of the paretic forelimb, can increase functional deﬁcits
(Bland et al., 2000), raisingdoubts on howearly any intervention should
be initiated after lesion. In our model, results suggest that initiating
inactivation of the contralesional hemisphere within hours following
the lesion has no long-termdetrimental effect on recovery of the paretic
forelimb, regardless of inactivation duration.
In humans, studies using a single inhibition treatment appear to
have short-lasting effects (Mansur et al., 2005; Nowak et al., 2008;
Takeuchi et al., 2005) in comparison to treatments using multiple
sessions (Emara et al., 2010; Fregni et al., 2006). However, to date,
there has been no systematic investigation of treatment duration on
motor outcomes. The comparison of Groups 3D, 7D and 14D conveys a
compellingmessage that increasing contralesional inactivation duration
promotes recovery of the paretic forelimb. Of course, due to numerous
differences such as the method of inhibition and limitations of our
animal model, absolute numbers for treatment duration in stroke
patients using non-invasive methods of inhibition cannot directly be
inferred from our data. However, it is interesting to note that the most
beneﬁcial treatment was of 14 days, a period that corresponds to the
time during which most of the spontaneous recovery occurs in our
model. In humans, this period of faster recovery is of approximately
one month, independently of the initial level of impairments (Duncan
and Lai, 1997). To date, treatment durations in human studies have all
been much shorter than this critical period. Whereas our data do not
resolve the issue of inhibition duration in humans after stroke, they do
strongly indicate that duration is a crucial factor to consider in treat-
ment design.
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